Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 22, 2017
Pharmacy Choice - News - Drug Delivery Systems - October 22, 2017

Pharmacy News

 Drug Delivery Systems
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 250     Next >>     Go To Page:

10/14/17 - Global IV Equipment Market to Reach US$ 12 Billion by 2022 Persistence Market Research [Emirates News Agency (WAM) (United Arab Emirates)]
-Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and fusion pumps, and a greater number of surgical procedures performed are poised to benefit the IV equipment market. The IV catheter segment is expected to be worth more than US$ 2.7 billion in 2017 itself and companies are recommended to target this s
10/14/17 - Methadone helps addicts through cravings, withdrawl
Alternatives to methadone include Suboxone or Subutex, which are taken in tablet form and were approved for use by the Food and Drug Administration in 2002. It is an effective alternative to methadone for pregnant women because it prevents fetal addiction to methadone, according to the National Institute on Drug Abuse, a division of the National In
10/14/17 - Optinose Announces Pricing of Initial Public Offering [DigitalProductionME.com]
-OptiNose, Inc., a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists, today announced the pricing of its initial public offering of 7,500,000 shares of common stock at a public offering price of $16.00 per share, before underwriting disc
10/13/17 - Aequus Granted Chinese Patent for Once Weekly Transdermal Aripiprazole
Release date- 12102017- VANCOUVER, BC.- Aequus Pharmaceuticals Inc., a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that the State Intellectual Property Office of the People's Republic of China has granted a Chinese patent for Aequus' once-weekly transdermal patch...
10/13/17 - Corporate News Blog - BioTime to Sublicense Hystem(R) to Processa Pharma for Developing Drug Delivery Platforms
LONDON, UK/ ACCESSWIRE/ October 13, 2017/ Pro-Trader Daily takes a look at the latest corporate events and news making the headlines for BioTime, Inc., following which, we have published a free report that can be viewed by signing up at http://protraderdaily.com/optin/? The Company announced on October 11, 2017, that it had finalized the terms for
10/13/17 - Data from Jadavpur University Provide New Insights into Drug Delivery Systems (Transport of magneto-nanoparticles during electro-osmotic flow in a...
By a News Reporter-Staff News Editor at Drug Week Current study results on Drugs and Therapies- Drug Delivery Systems have been published. According to news reporting originating in Kolkata, India, by NewsRx journalists, research stated, "In this paper, we have examined the motion of magnetic-nanoparticles and the flow characteristics of biofluid
10/13/17 - Data from M.C. Tadini and Colleagues Advance Knowledge in Infectious Diseases (Method validation and nanoparticle characterization assays for an...
Data from M.C. Tadini and Colleagues Advance Knowledge in Infectious Diseases. By a News Reporter-Staff News Editor at Drug Week Researchers detail new data in Infectious Diseases. According to news reporting out of Ribeirao Preto, Brazil, by NewsRx editors, research stated, "Drug Delivery Systems of known drugs are prominent candidates towards n
10/13/17 - Data on Drug Delivery Systems Discussed by Researchers at Guru Gobind Singh Indraprastha University (Synthesis and characterization of...
Data on Drug Delivery Systems Discussed by Researchers at Guru Gobind Singh Indraprastha University. According to news originating from New Delhi, India, by NewsRx correspondents, research stated, "In this study, we have synthesized magnetic nanocomposites of magnetite nanoparticles coated with 6- aminohexanoic acid and pectin. Our news journalists
10/13/17 - Global IV Equipment Market to Reach US$ 12 Billion by 2022 Persistence Market Research
Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and fusion pumps, and a greater number of surgical procedures performed are poised to benefit the IV equipment market. The IV catheter segment is expected to be worth more than US$ 2.7 billion in 2017 itself and companies are recommended to target this
10/13/17 - Investigators at Ruprecht-Karls-University Detail Findings in Antibiotics (Oral delivery of vancomycin by tetraether lipid liposomes)
By a News Reporter-Staff News Editor at Drug Week Investigators discuss new findings in Drugs and Therapies- Antibiotics. According to news reporting out of Heidelberg, Germany, by NewsRx editors, research stated, "Despite the outstanding progress in modern medicine, the oral delivery of peptide drugs is limited until today due to their instabili
10/13/17 - Janssen Submits New Drug Application to U.S. FDA for Apalutamide
Release date- 12102017- HORSHAM, PA- Janssen Biotech, Inc. today announced that it has submitted a New Drug Application to the U.S. Food and Drug Administration for apalutamide, an investigational, next generation oral androgen receptor inhibitor for men with non-metastatic castration-resistant prostate cancer. Currently, there are no FDA approved.
10/13/17 - Jubilant DraxImage receives approval from Health Canada for the RUBY Elution System? (RbES) and proprietary RUBY? Consumable Accessories
Jubilant DraxImage Inc., a Jubilant Pharma whollyowned subsidiary, is pleased to announce it has received approval from Health Canada for its state-ofthe-art RUBY Elution System and the proprietary RUBY consumable accessories for use with the already approved RUBY-FILL Rubidium-82 Generator for Positron Emission Tomography of the myocardium..
10/13/17 - New Drug Delivery Systems Findings Has Been Reported by Investigators at Soochow University (Polyglycerol mediated covalent construction of magnetic...
New Drug Delivery Systems Findings Has Been Reported by Investigators at Soochow University. According to news reporting out of Jiangsu, People's Republic of China, by NewsRx editors, research stated, "Construction of nanohybrids with chemical and colloidal stability is of great importance for the exploration of their potential applications in...
10/13/17 - New Drug Delivery Systems Study Findings Have Been Reported from Sichuan University (K+-Responsive Block Copolymer Micelles for Targeted...
New Drug Delivery Systems Study Findings Have Been Reported from Sichuan University. According to news reporting from Chengdu, People's Republic of China, by NewsRx journalists, research stated, "In this work, a novel type of block copolymer micelles with K+- responsive characteristics for targeted intracellular drug delivery is developed.
10/13/17 - New Drug Delivery Systems Study Findings Reported from Soochow University [Effect of pH on polyethylene glycol (PEG)-induced silk microsphere...
New Drug Delivery Systems Study Findings Reported from Soochow University. According to news reporting from Suzhou, People's Republic of China, by NewsRx journalists, research stated, "The effects of changing solution pH in the range of 3.6-10.0 during a one-step silk microsphere preparation process, by mixing silk and polyethylene glycol, was asse
10/13/17 - Opiant Pharmaceuticals, Inc. Reports Fiscal Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company developing pharmacological treatments for addictions, today reported financial results for the fiscal fourth quarter and year ended July 31, 2017.. Received an additional $3.75 million in funding from SWK Funding LLC, which was triggered by surpassing $25.0 million of net sales of N
10/13/17 - Optinose Announces Pricing of Initial Public Offering
OptiNose, Inc., a specialty pharmaceutical company focused on the development and commercialization of products for patients treated by ear, nose and throat and allergy specialists, today announced the pricing of its initial public offering of 7,500,000 shares of common stock at a public offering price of $16.00 per share, before underwriting dis
10/13/17 - Patent Application Titled "Connecting System, Injection System for the Injection of a Medical Fluid and Method of Operating Such an Injection System"...
Patent Application Titled "Connecting System, Injection System for the Injection of a Medical Fluid and Method of Operating Such an Injection System" Published Online. By a News Reporter-Staff News Editor at Health& Medicine Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inve
10/13/17 - Patent Application Titled "Pharmaceutical Formulations That Form Gel in Situ" Published Online (USPTO 20170266294)
By a News Reporter-Staff News Editor at Drug Week According to news reporting originating from Washington, D.C., by NewsRx journalists, a patent application by the inventors BALDWIN, John J.; WEI, Gang, filed on October 25, 2016, was made available online on September 28, 2017. No assignee for this patent application has been made. Reporters obta
10/13/17 - Recent Research from St. Louis University Highlight Findings in Drug Delivery Systems [Development of rhenacarborane complexes as central nervous...
By a News Reporter-Staff News Editor at Drug Week A new study on Drugs and Therapies- Drug Delivery Systems is now available. According to news reporting out of St. Louis, Missouri, by NewsRx editors, research stated, "The search for non-invasive neural therapeutics is a problematic pursuit often hindered by the blood-brain barrier, a gatekeeper
10/13/17 - Reports from University of Claude Bernard Add New Data to Findings in Drug Delivery Systems (Pickering emulsions stabilized by biodegradable block...
Reports from University of Claude Bernard Add New Data to Findings in Drug Delivery Systems. According to news originating from Lyon, France, by NewsRx correspondents, research stated, "Surfactant-free biocompatible and biodegradable Pickering emulsions were investigated as vehicles for skin delivery of hydrophobic drugs. Our news journalists obtai
10/13/17 - Reports from University of Crete Advance Knowledge in Drug Delivery Systems (OH-functionalization strategy in Metal-Organic Frameworks for drug...
According to news reporting originating from Iraklion, Greece, by NewsRx correspondents, research stated, "With the goal in mind of developing new and much-improved drug anchoring regimes, we strategically modified the organic linker of IRMOF-16 by introducing hydroxyl groups." Our news editors obtained a quote from the research from the University
10/13/17 - Reports from University of Liverpool Add New Data to Findings in Drug Delivery Systems (Development of a Poly-epsilon-Lysine Contact Lens as a Drug...
Reports from University of Liverpool Add New Data to Findings in Drug Delivery Systems. According to news reporting from Liverpool, United Kingdom, by NewsRx journalists, research stated, "The purpose of this study was to develop a more efficient drug delivery device to overcome the limitations of current drop therapy for the treatment of fungal ke
10/13/17 - Research Conducted at University of Jinan Has Updated Our Knowledge about Drug Delivery Systems (Liposomes coated with thiolated chitosan as drug...
According to news reporting originating in Guangdong, People's Republic of China, by NewsRx journalists, research stated, "Liposome is one of a promising delivery system to improve water solubility, stability, and bioavailability of curcumin. Funders for this research include National Natural Science Foundation of China, Science and Technology Proj
10/13/17 - Shionogi Inc. and Purdue Pharma L.P. Announce U.S. Availability of Symproic (naldemedine) for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain [T-break Tech (Middle East)]
Shionogi Inc. and Purdue Pharma L.P. announced today that Symproic 0.2 mg tablets are now available throughout the United States. We are very pleased to launch Symproic with our partner, Purdue Pharma, in the U.S. Together we are providing a new treatment option for many adult patients with chronic non-cancer pain who suffer from opioid-induced con
Articles(s): 1 - 25 of 250     Next >>     Go To Page:


© 2017 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415